Avenue Therapeutics, Inc.
Hedge Funds Holdings

Last updated:

Avenue Therapeutics, Inc.‘s stocks are currently a part of 9 hedge funds’ portfolios, which represents 6.15% of the total amount of its stocks outstanding. This makes up a total of 134.41K shares of Avenue Therapeutics, Inc.. Compared to the previous quarter, the number fell by -70.05% or -314.4K shares fewer. As for the holding position changes, 22.22% (2) of current hedge fund investors increased the number of shares held, and 44.44% (4) closed the holdings completely. 5 hedge funds are new holders of Avenue Therapeutics, Inc. stock in Q1 2023, it is 55.56% of total holders.

Hedge funds holding Avenue Therapeutics (Q2 2018 – Q1 2023)

Number of hedge funds
Q2 2018 7
Q3 2018 7
Q4 2018 7
Q1 2019 13
Q2 2019 12
Q3 2019 15
Q4 2019 14
Q1 2020 20
Q2 2020 36
Q3 2020 33
Q4 2020 35
Q1 2021 33
Q2 2021 25
Q3 2021 18
Q4 2021 15
Q1 2022 13
Q2 2022 16
Q3 2022 10
Q4 2022 13
Q1 2023 9

Hedge funds changes in Avenue Therapeutics positions (Q2 2018 – Q1 2023)

Changes in positions
Q2 2018 23101
Q3 2018 12211
Q4 2018 2222-1
Q1 2019 63202
Q2 2019 15321
Q3 2019 44412
Q4 2019 3634-2
Q1 2020 10704-1
Q2 2020 201124-1
Q3 2020 312136-1
Q4 2020 814661
Q1 2021 310956
Q2 2021 1031118-17
Q3 2021 45511-7
Q4 2021 2555-2
Q1 2022 16231
Q2 2022 52720
Q3 2022 100016-16
Q4 2022 7404-2
Q1 2023 5204-2

Top 50 hedge fund holders of Avenue Therapeutics, Inc. (NASDAQ:ATXI)